EPISODE · Sep 29, 2025 · 7 MIN
#045 The $SVRA Smokescreen How a Missing Drug File Crushed Shareholders
from SueWallSt · host SueWallSt
What happens when a biotech company tells investors one thing and delivers another? In this episode of Sue Wall Street, we unpack the securities class action against Savara Inc. $SVRA’s inhaled drug for rare lung disease was supposed to be a breakthrough—until the FDA refused to even review their application. If you're a biotech investor, compliance nerd, or just love a good Wall Street unraveling, this deep dive is for you. Visit ZLK.com for more info. Add our WhatsApp Channel. We’re not lawyers or accountants, so don’t take this as legal or financial advice.
What this episode covers
What happens when a biotech company tells investors one thing and delivers another? In this episode of Sue Wall Street, we unpack the securities class action against Savara Inc. $SVRA’s inhaled drug for rare lung disease was supposed to be a breakthrough—until the FDA refused to even review their application. If you're a biotech investor, compliance nerd, or just love a good Wall Street unraveling, this deep dive is for you. Visit ZLK.com for more info. Add our WhatsApp Channel. We’re not lawyers or accountants, so don’t take this as legal or financial advice.
NOW PLAYING
#045 The $SVRA Smokescreen How a Missing Drug File Crushed Shareholders
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.